Ranbaxy and Teva also received FDA approval for lisinopril and hydrochiorothiazide tablets in 10 mg/12.5 mg, 20 mg/12.5 mg and 20 mg/25 mg

Drug Store News, August 12, 2002

> Ranbaxy and Teva also received F DA approval for lisinopril and hydrochiorothiazide tablets in 10 mg/12.5 mg, 20 mg/12.5 mg and 20 mg/25 mg. It is bioequivalent to Prinzide and Zestoretic. Mylan Laboratories received approval for lisinopril tablets in 2.5 mg, 5 mg, 10 20 mg, 30 mg and 40 mg strengths and lisinopril and hydrochiorothiazicte tablets in 10 mg/12.5 mg, 20 mg/12.5 mg and 20 mg/25 mg strengths.